YSB

YSB P/B

The P/B (Price-to-Book Ratio) of YSB (9885.HK) as of Oct 20, 2026 is 1.06. In the previous year, P/B (Price-to-Book Ratio) was 1.31 — a change of -18.52% (lower).

P/B

1.06

YoY

-18.52%

Last updated:

P/B (Price-to-Book Ratio) of YSB is 2025 1.06 . P/B (Price-to-Book Ratio) of YSB was 2024 1.31 . It decreases by -18.52% lower compared to the previous year.

The YSB P/B history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/B
Date
P/B
Jan 1, 2020
-1.06 CNY
Jan 1, 2021
-0.90 CNY
Jan 1, 2022
-0.70 CNY
Jan 1, 2023
1.58 CNY
Jan 1, 2024
1.31 CNY
Jan 1, 2025
1.06 CNY
The YSB P/B history
YEARP/BYoY
1.06-18.52%
1.31-17.22%
1.58-326.63%
-0.70-22.37%
-0.90-15.12%
-1.06—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

YSB Stock analysis

What does YSB do? YSB, Inc. generates revenue through the wholesale and retail of pharmaceuticals and healthcare products via offline and online platforms. The company operates an online platform enabling pharmaceutical distributors to sell their products, while also offering software-as-a-service (SaaS) solutions to pharmacies. Additionally, YSB sells smart unmanned pharmaceutical booths to third-party pharmacies and provides maintenance and technical support services for these booths. The firm's primary market is domestic, serving pharmacies, distributors, and primary medical institutions through its SaaS and testing services. The company's SaaS solutions target pharmacies, helping them manage operations, while the smart unmanned pharmaceutical booths are sold to third-party pharmacies for retail distribution. Medical testing services are provided directly to primary medical institutions, and the firm's online platform connects distributors with buyers. All services and products are focused on the domestic market, with no international operations mentioned in the description. YSB, Inc. makes money by selling pharmaceuticals and healthcare products through its platforms, offering SaaS to pharmacies, and providing maintenance services for smart booths. The firm's revenue streams include direct sales of products, SaaS subscriptions, booth sales, and technical support contracts. Primary customers are pharmacies, distributors, and primary medical institutions, all operating within China's domestic market. YSB is one of the most popular companies on Eulerpool.

Frequently Asked Questions about YSB stock

P/B (Price-to-Book Ratio) of YSB is 1.06 in 2025.

P/B (Price-to-Book Ratio) of YSB changed from 1.31 to 1.06, representing a -18.52% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) YSB since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s YSB with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — YSB

All Key Metrics — YSB